Research of adiponutrin gene (PNPLA3) in indigenous people of the Republic Sakha (Yakutia) with type 2 diabetes
https://doi.org/10.25789/YMJ.2018.61.02
Abstract
Polymorphism of the I148M Gene of the PNPLA3 Gene was studied in patients with type 2 diabetes of the Yakut nationality. The predominance of the GG Genotype (58.5%) with a G-allele frequency of 74.1% was revealed. The normally functioninG protein of the PNPLA3 Gene reGulates the activity of triGlyceride hydrolase and lysophosphatidic acid acyltransferase. It is likely that the hiGh frequency of the mutant allele G in the Yakuts with type 2 diabetes may be one of the causes of the lipid metabolism mechanism disorder in the liver.
Keywords
About the Authors
Kh. A. KurtanovRussian Federation
Kurtanov Khariton Alekseevich - Candidate of Medical Science, Chief Researcher, Head of the Department of Molecular Genetics
Yakutsk, Republic Sakha (Yakutia)
N. I. Pavlova
Russian Federation
Pavlova Nadejda Ivanovna – Candidate of Biological Sciences, Leading Researcher, Head of the Laboratory of Hereditary Pathology
Yakutsk, Republic Sakha (Yakutia)
N. P. Filippova
Russian Federation
Filippova Natalya Pavlovna – Candidate of Biological Sciences, Senior Researcher of the Laboratory of Hereditary Pathology
Yakutsk, Republic Sakha (Yakutia)
G. A. Apsolikhova
Russian Federation
Apsolikhova Galina Aleksandrovna – junior researcher of the laboratory of hereditary pathology
Yakutsk, Republic Sakha (Yakutia)
N. A. Solovieva
Russian Federation
Solovieva Natalya Alekseevna – Candidate of Biological Sciences, Leading Researcher, Head of the Laboratory of Population Genetics
Yakutsk, Republic Sakha (Yakutia)
V. V. Dodokhov
Russian Federation
Dodokhov Vladimir Vladimirovich – Candidate of Biological Sciences, Senior Researcher of the Laboratory of Hereditary Pathology
Yakutsk, Republic Sakha (Yakutia)
M. A. Varlamova
Russian Federation
Varlamova Marina Alekseyevna – researcher of the Laboratory of hereditary pathology
Yakutsk, Republic Sakha (Yakutia)
A. T. Dyakonova
Russian Federation
Dyakonova Aleksandra Timofeyevna – researcher of the laboratory of hereditary pathology
Yakutsk, Republic Sakha (Yakutia)
L. M. Neustroyeva
Russian Federation
Neustroyeva Lena Mikhaylovna – researcher of the Laboratory of Population Genetic
Yakutsk, Republic Sakha (Yakutia)
N. V. Borisova
Russian Federation
Natalya Vladimirovna Borisova - doctor of Medical Sciences, Professor of the Department «Normal and Pathological Physiology»
Yakutsk, Republic Sakha (Yakutia)
L. A. Sydykova
Russian Federation
Sydykova Lyubovy Akhmedovna - Candidate of Medical Science, Head of Department of propaedeutic and faculty therapy with endocrinology and physical therapy
Yakutsk, Republic Sakha (Yakutia)
References
1. Biryukova E.V. Diabetes mellitus type 2 and non-alcoholic fatty liver disease – diseases of the present / E.V. Biryukova, S.V. Rodionova // Medical almanac. – 2017. – №6(51). – P.130-135.
2. Investigation of polymorphism association of the PNPLA3 gene with non-alcoholic fatty liver disease in the Uzbek population / М.М. Karimov, D.A. Dalimova, G.N. Sobirova [et al.] // Eurasian Journal of Internal Medicine. – 2015. – №02 (02). – P.25-27.
3. Komshilova K.A. Non-alcoholic fatty liver disease at obesity / K.A. Komshilova, E.A. Troshina, S.A. Butrova // Obesity and Metabolism. – 2011. – №3. – P.3-11.
4. Molecular genetic analysis of the marker rs738409 of the adiponutrin gene (PNPLA3) in the Yakut population / Kh.A. Kurtanov, N.I. Pavlova, N.P. Filippova // genetics of man and pathology: a collection of scientific works. – 2017. – №11. – P.82-84.
5. Non-alcoholic fatty liver disease: a manual for doctors / I.V. Maev, D.N. Andreev, D.T. Dichev [et al.]. – M.:Prima Print. – 2017. – P.64.
6. Mohort T.V. Non-alcoholic fatty liver disease and diabetes mellitus: pathogenesis, diagnosis and treatment aspects/ T.V. Mohort // Medical News. – 2012. – №4. – P.4-10.
7. Nikolaeva L.A. Modern ideas about the etiology and primary prevention of essential hypertension / LA. Nikolaeva, Т.E. Burtseva, V.G. Chasnyk // Yakutsk Medical Journal. – 2007. – №3. – P.57-59.
8. Petunina N.A. Non-alcoholic fatty liver disease / N.A. Petunina, M.E. Tel’nova // Medical advice. – 2016. – №4. – P.92-95.
9. Association of non-alcoholic fatty liver disease and type 2 diabetes mellitus / L.A. Sharonova, A.F. Verbova, N.I. Verbova [et al.] // RMJ. – 2017. – № 22. – P.1635-1640.
10. Association of PNPLA3 SNP rs738409 with liver density in african americans with type 2 diabetes mellitus / AJ. Cox, MR. Wing, JJ. Carr, [et al.] // Diabetes & metabolism. – 2011. – Vol. 37, №5. – P.452-455. doi:10.1016/j.diabet.2011.05.001.
11. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease / K. Hotta, M. Yoneda, H. Hyogo [et al.] // BMC Med. genet. – 2010. – Vol. 11. – P.172.
12. Specifically PNPLA3-Mediated Accumulation of Liver Fat in Obese Patients with Type 2 Diabetes / J-M. Petit, B. Guiu, D. Masson [et al.] // The Journal of Clinical Endocrinology & Metabolism. – Vol. 95. – №12. – P.E430–E436 https://doi.org/10.1210/jc.2010-0814
13. Kan H. Influence of the rs738409 polymorphism in patatin-like phospholipase 3 on the treatment efficacy of non-alcoholic fatty liver disease with type 2 diabetes mellitus / H. Kan, H. Hyogo, H. Ochi, // Hepatol Res. – 2016. – Vol.46– E146–E153. doi: 10.1111/hepr.12552.
14. Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent / S. Romeo, F. Sentinelli, S. Dash [et al.] // Int. J . Obes. (Lond). – 2010. – Vol.34. – P.190–194.
15. Costs and consequence associatiated with newer medications for glycemic control in type 2 diabetes / A. Sinha, M. Ragan, T. Hoerger [et al.] // Diabetes Care. – 2010. – Vol. 33. – P.695–700.
16. The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus/ M. Ueyama, N. Nishida, M. Korenaga [et al.] //J gastroenterol. – 2015. – Vol. 51(4). – 370-9. doi: 10.1007/s00535-015-1116-6. Epub 2015 Sep 3.
17. Day CP: Homozygosity for the patatin-like phospholipase-3/adiponutrin I148 M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease / L. Valenti, A. Al-Serri, AK. Daly [et al.]// Hepatology. – 2010. – Vol.51. – P.1209-1217. 10.1002/hep.23622.
18. Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study / LE. Wagenknecht, ND. Palmer, DW. Bowden [et al.] // Liver international: official journal of the International Association for the Study of the Liver. – 2011. – Vol. 31(3). – P.412-416. doi:10.1111/j.1478-3231.2010.02444.x.
19. Wilfred de Alwis N.M. Genetics of Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease / N.M. Wilfred de Alwis, C.P. Day // Seminars in Liver Disease. – 2007. – Vol. 27. – P. 44-54.
20. http://www.internationalgenome.org/
Review
For citations:
Kurtanov Kh.A., Pavlova N.I., Filippova N.P., Apsolikhova G.A., Solovieva N.A., Dodokhov V.V., Varlamova M.A., Dyakonova A.T., Neustroyeva L.M., Borisova N.V., Sydykova L.A. Research of adiponutrin gene (PNPLA3) in indigenous people of the Republic Sakha (Yakutia) with type 2 diabetes. Yakut Medical Journal. 2018;(1):11-14. https://doi.org/10.25789/YMJ.2018.61.02